<DOC>
	<DOCNO>NCT01070433</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy MEBO treatment subject diabetic foot ulcer ( DFUs ) .</brief_summary>
	<brief_title>A Clinical Study Safety Efficacy MEBO Wound Ointment Subjects With Diabetic Foot Ulcers</brief_title>
	<detailed_description>This phase II , randomize , control , multi-center study design ass safety efficacy MEBO treatment subject DFUs . Subjects meet entry criterion randomly assign 1:1 ratio 8 week treatment either MEBO SOC .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Male female ≥18 year age Able willing provide inform consent Able willing comply protocol visit procedure Target ulcer duration ≥4 week Ulcer nondiabetic pathophysiology Known suspect allergy component MEBO Malignancy target ulcer foot Noncompliance screen runin period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetic Foot Ulcers ( DFUs )</keyword>
</DOC>